Summary of Significant Accounting Policies (Tables)

9 Months Ended

Mar. 31, 2023

Accounting Policies [Abstract]

Schedule of Net Revenue Disaggregated by Product and Region

The following table summarizes our net revenue disaggregated by segment, product and region (in thousands):

	Three Months Ended March 31,				Nine Months Ended March 31,
	2023		2022		2023		2022
U.S., Canada and Latin America
Devices	$	372,071	$	250,768	$	1,057,141	$	771,475
Masks and other	257,070		224,665		765,364		681,803
Total U.S., Canada and Latin America	$	629,141	$	475,433	$	1,822,505	$	1,453,278
Combined Europe, Asia and other markets
Devices	$	235,818	$	182,307	$	611,123	$	608,268
Masks and other	115,157		105,618		307,913		304,151
Total Combined Europe, Asia and other markets	$	350,975	$	287,925	$	919,036	$	912,419
Global revenue
Total Devices	$	607,889	$	433,075	$	1,668,264	$	1,379,743
Total Masks and other	372,227		330,283		1,073,277		985,954
Total Sleep and Respiratory Care	$	980,116	$	763,358	$	2,741,541	$	2,365,697
Software as a Service	136,782		101,142		359,395		297,693
Total	$	1,116,898	$	864,500	$	3,100,936	$	2,663,390

Schedule of Contract Balances

The following table summarizes our contract balances (in thousands):

	March 31, 2023		June 30, 2022		Balance sheet caption
Contract assets
Accounts receivable, net	$	686,264	$	575,950	Accounts receivable, net
Unbilled revenue, current	25,904		25,692		Prepaid expenses and other current assets
Unbilled revenue, non-current	9,700		8,840		Prepaid taxes and other non-current assets
Contract liabilities
Deferred revenue, current	(141,043)		(108,667)		Deferred revenue (current liabilities)
Deferred revenue, non-current	(108,875)		(95,455)		Deferred revenue (non-current liabilities)